TABLE 3.
Parameter | SARS‐CoV‐2, symptomatic | SARS‐CoV‐2, asymptomatic | Control | P‐value |
---|---|---|---|---|
Shortness of breath | n = 5 | n = 23 | n = 16 | |
%Pred 6MWT distance, % | 79 ± 15†† | 101 ± 15** | 101 ± 11* | 0.008** |
ΔHR rest to post‐6MWT, beats/min | +32 ± 17 † | +56 ± 18* | +65 ± 18** | 0.003** |
HRR1min, beats/min | −13 ± 9 | −23 ± 10 | −29 ± 10** | 0.009** |
Joint/muscle aches | n = 4 | n = 24 | n = 16 | |
%Pred 6MWT distance, % | 80 ± 19† | 100 ± 16* | 101 ± 11* | 0.044* |
ΔHR rest to post‐6MWT, beats/min | +44 ± 32 | +53 ± 18 | +65 ± 18 | 0.068 |
HRR1min, beats/min | −13 ± 12 | −23 ± 9 | −29 ± 10* | 0.014* |
Fatigue | n = 3 | n = 25 | n = 16 | |
%Pred 6MWT distance, % | 87 ± 24 | 98 ± 16 | 101 ± 11 | 0.359 |
ΔHR rest to post‐6MWT, beats/min | +40 ± 24 | +53 ± 20 | +65 ± 18 | 0.050* |
HRR1min, beats/min | −11 ± 6 | −23 ± 10 | −29 ± 10* | 0.011* |
Cough | n = 4 | n = 24 | n = 16 | |
%Pred 6MWT distance, % | 90 ± 15 | 98 ± 18 | 101 ± 11 | 0.493 |
ΔHR rest to post‐6MWT, beats/min | +45 ± 28 | +53 ± 19 | +65 ± 18 | 0.076 |
HRR1min, beats/min | −19 ± 11 | −22 ± 10 | −29 ± 10 | 0.071 |
Loss of taste/smell | n = 10 | n = 18 | n = 16 | |
%Pred 6MWT distance, % | 89 ± 20 | 102 ± 14 | 101 ± 11 | 0.092 |
ΔHR rest to post‐6MWT, beats/min | +47 ± 23 | +54 ± 19 | +65 ± 18 | 0.060 |
HRR1min, beats/min | −19 ± 13 | −23 ± 8 | −29 ± 10* | 0.041* |
Cognitive impairment | n = 3 | n = 25 | n = 16 | |
%Pred 6MWT distance, % | 84 ± 19 | 99 ± 17 | 101 ± 11 | 0.229 |
ΔHR rest to post‐6MWT, beats/min | +64 ± 32 | +50 ± 19 | +65 ± 18 † | 0.046* |
HRR1min, beats/min | −14 ± 12 | −22 ± 10 | −29 ± 10 | 0.034* |
Abbreviations: HR, heart rate; HRR1min, the difference in HR immediately post‐6MWT compared with the initial minute of recovery; 6MWT, 6‐minute walk test; %Pred 6MWT distance, distance travelled during the 6MWT normalized to a reference sample using predictive equations provided by Casanova et al. (2011); SARS‐CoV‐2, severe acute respiratory syndrome coronavirus 2. Note: Significant differences from symptomatic groups are indicated as follows
P ≤ 0.05
P ≤ 0.01. Significant differences from asymptomatic groups are indicated as follows
† P ≤ 0.05
†† P ≤ 0.01.